Guideline sources The following summarized guidelines for the management of secondary hypersomnia are prepared by our editorial team based on guidelines from the American Academy of Sleep Medicine (AASM 2021). 1 Guidelines 1. Specific circumstances Patients with neurological diseases: Consider offering the following medications for the treatment of adult patients with hypersomnia secondary to Parkinson's disease: modafinil sodium oxybate. C Show 2 more Patients with myotonic dystrophy: consider offering modafinil for the treatment of adult patients with hypersomnia secondary to myotonic dystrophy. C Patients with post-traumatic hypersomnia: Consider offering the following medications for the treatment of adult patients with hypersomnia secondary to TBI: armodafinil modafinil. C References https://web.pathway.md/diseases/recslRPucyLNSmHot 1/2 6/24/23, 3:06 PM Secondary hypersomnia Pathway 1. Kiran Maski, Lynn Marie Trotti, Suresh Kotagal et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021 Sep 1;17 9 1881 1893. Open https://web.pathway.md/diseases/recslRPucyLNSmHot 2/2